Produced in rabbits immunized with E. coli-derived Human DRD1 fragment, and purified by antigen affinity chromatography.
Source
Polyclonal Rabbit IgG
Purification
Protein A & Antigen Affinity
Formulation
PBS, pH7.0 with 0.03% Proclin300
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Avoid repeated freeze-thaw cycles.
The dopamine 1 receptor (DRD1) is thought to mediate some of the cognitive deficits in schizophrenia (SCZ), including impairment of working memory that relies on normal dorsolateral prefrontal cortex (DLPFC) function. DRD1 is a typical G protein-coupled receptor (GPCR) mainly expressed in the neurogenic area, with high constitutive activity. The receptor appears in the embryonic period before the formation of mature synaptic contacts, which indicates that the dopamine receptor and its constitutive activity play crucial roles in embryonic brain development. Cells expressing the DRD1 have significant functional roles in diverse physiological processes including locomotion and drug addiction. Neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP).
References
Yao F, et al. (2013) A tet-on system for drd1-expressing cells. PLoS One 8 (8): e72681.
Yan Y, et al. (2015) Dopamine controls systemic inflammation through inhibition of nlrp3 inflammasome. Cell 160 (1-2): 62-73.
Wang Q, et al. (2020) Constitutive activity of a g protein-coupled receptor, drd1, contributes to human cerebral organoid formation. Stem Cells 38 (5): 653-665.
Kaalund SS, et al. (2014) Contrasting changes in drd1 and drd2 splice variant expression in schizophrenia and affective disorders, and associations with snps in postmortem brain. Mol Psychiatry 19 (12): 1258-1266.